Company Profile

Genetic Vectors Inc
Profile last edited on: 2/8/19      CAGE:       UEI:

Business Identifier: Nucleic acid labeling and detection technology
Year Founded
1991
First Award
1993
Latest Award
2000
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5201 Northwest 77th Avenue Suite 100
Miami, FL 33166
   (305) 716-0000
   N/A
   www.gvec.com
Location: Single
Congr. District: 25
County: Miami-Dade

Public Profile

Genetic Vectors, Inc. (OTC: GVEC) was a biotechnology company developing diagnostic and quality control tools for the biotechnology and molecular biology markets. The technology intended to allow biopharmaceutical companies in monitoring the purity. The company owned proprietary rights over the EpiDNA technology for the labeling and detection of nucleic acids, particularly in DNA. The technology was the basis for the company's product line EpiDNA, the Picogram assay and EasyID - technology utilized for the detection of yeasts in the food and beverage and the brewing and wine making industry. The company acquired DNA Sciences, Inc. during January 2000 but was delisted shortly therafter. In October 2001, complet inventory of the firm was auctioned off.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
OTC : GVEC
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2000 1 NIH $100,000
Project Title: Novel RNASE Protection Assay For Cytokine MRNAS
1997 1 NIH $99,897
Project Title: Rapid Identification Of Fungal Species
1993 1 NIH $49,998
Project Title: Non radioactive nucleic acid labeling technology

Key People / Management

  Mead M McCabe -- President

Company News

There are no news available.